Castle Biosciences annual gross margin
2018
2019
2020
Castle Biosciences Gross Margin Growth & History (CSTL)
Castle Biosciences's gross margin was 84.54% for fiscal 2020.
View full Castle Biosciences company overviewCastle Biosciences annual gross margin history
| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | 84.54% | −1.36 pp |
| 2019 | 2019-12-31 | 85.91% | +9.15 pp |
| 2018 | 2018-12-31 | 76.75% | — |
Castle Biosciences quarterly gross margin
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2021 | 2021-03-31 | 86.73% | +0.45 pp |
| Q4 2020 | 2020-12-31 | 84.55% | −4.05 pp |
| Q3 2020 | 2020-09-30 | 83.74% | −4.70 pp |
| Q2 2020 | 2020-06-30 | 83.12% | +1.68 pp |
| Q1 2020 | 2020-03-31 | 86.27% | +4.60 pp |
| Q4 2019 | 2019-12-31 | 88.60% | +24.99 pp |
| Q3 2019 | 2019-09-30 | 88.44% | +21.78 pp |
| Q2 2019 | 2019-06-30 | 81.44% | — |
| Q1 2019 | 2019-03-31 | 81.67% | — |
| Q3 2018 | 2018-09-30 | 63.61% | — |
| Q2 2018 | 2018-06-30 | 66.66% | — |
Castle Biosciences gross margin trends
Across the available reported history, Castle Biosciences's gross margin decreased from 85.91% to 84.54%, a change of −1.36 percentage points. The latest reported quarter, Q1 2021, shows 86.73%.
About the metric
What gross margin means
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
Calculation and source
How gross margin is calculated
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Castle Biosciences filings at SEC.gov ↗